Brian Ackerman
About Brian Ackerman
Brian Ackerman serves as the Corporate Controller at Supernus Pharmaceuticals, Inc., a position he has held since 2020. He has a background in accounting and auditing, with previous roles at KPMG US and Supernus Pharmaceuticals.
Work at Supernus Pharmaceuticals
Brian Ackerman has served as the Corporate Controller at Supernus Pharmaceuticals, Inc. since 2020. In this role, he oversees financial reporting and compliance, ensuring the accuracy of the company's financial statements. Prior to his current position, he worked as Associate Controller at Supernus from 2017 to 2020, where he contributed to the financial management and strategic planning of the organization. His experience at Supernus has provided him with a comprehensive understanding of the pharmaceutical industry and its financial operations.
Experience at KPMG US
Brian Ackerman has extensive experience at KPMG US, where he held several key positions. He began as a Senior Associate from 2010 to 2013 in the Baltimore, Maryland Area. He then progressed to Audit Manager from 2013 to 2015, further developing his expertise in audit processes. After that, he served as Audit Senior Manager from 2015 to 2017, leading audit teams and managing client relationships. His tenure at KPMG equipped him with strong analytical skills and a deep understanding of financial regulations.
Education and Expertise
Brian Ackerman earned his Bachelor of Science (BS) degree in Accounting and Information Systems from the University of Maryland, completing his studies from 2002 to 2007. His educational background has provided him with a solid foundation in accounting principles and information systems, which he has applied throughout his career in finance and auditing. This academic training supports his current role in financial management and reporting.
Professional Background
Brian Ackerman has built a career in finance and accounting, with significant experience in both corporate and public accounting. His roles have included various levels of responsibility, from audit associate to corporate controller. His professional journey reflects a commitment to financial integrity and compliance, as well as a focus on strategic financial management within the pharmaceutical sector.